238 related articles for article (PubMed ID: 29273385)
61. Hepatic storage of glycosaminoglycans in feline and canine models of mucopolysaccharidoses I, VI, and VII.
Haskins ME; Otis EJ; Hayden JE; Jezyk PF; Stramm L
Vet Pathol; 1992 Mar; 29(2):112-9. PubMed ID: 1632054
[TBL] [Abstract][Full Text] [Related]
62. Validation of disaccharide compositions derived from dermatan sulfate and heparan sulfate in mucopolysaccharidoses and mucolipidoses II and III by tandem mass spectrometry.
Tomatsu S; Montaño AM; Oguma T; Dung VC; Oikawa H; Gutiérrez ML; Yamaguchi S; Suzuki Y; Fukushi M; Barrera LA; Kida K; Kubota M; Orii T
Mol Genet Metab; 2010 Feb; 99(2):124-31. PubMed ID: 19932038
[TBL] [Abstract][Full Text] [Related]
63. Nonviral in vivo gene transfer in the mucopolysaccharidosis I murine model.
Camassola M; Braga LM; Delgado-Cañedo A; Dalberto TP; Matte U; Burin M; Giugliani R; Nardi NB
J Inherit Metab Dis; 2005; 28(6):1035-43. PubMed ID: 16435197
[TBL] [Abstract][Full Text] [Related]
64. Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I.
Kakkis E; McEntee M; Vogler C; Le S; Levy B; Belichenko P; Mobley W; Dickson P; Hanson S; Passage M
Mol Genet Metab; 2004; 83(1-2):163-74. PubMed ID: 15464431
[TBL] [Abstract][Full Text] [Related]
65. alpha-L-iduronidase premature stop codons and potential read-through in mucopolysaccharidosis type I patients.
Hein LK; Bawden M; Muller VJ; Sillence D; Hopwood JJ; Brooks DA
J Mol Biol; 2004 Apr; 338(3):453-62. PubMed ID: 15081804
[TBL] [Abstract][Full Text] [Related]
66. Biodistribution and pharmacodynamics of recombinant human alpha-L-iduronidase (rhIDU) in mucopolysaccharidosis type I-affected cats following multiple intrathecal administrations.
Vite CH; Wang P; Patel RT; Walton RM; Walkley SU; Sellers RS; Ellinwood NM; Cheng AS; White JT; O'Neill CA; Haskins M
Mol Genet Metab; 2011 Jul; 103(3):268-74. PubMed ID: 21482164
[TBL] [Abstract][Full Text] [Related]
67. Mucopolysaccharidosis type II (Hunter syndrome): Clinical and biochemical aspects of the disease and approaches to its diagnosis and treatment.
Mohamed S; He QQ; Singh AA; Ferro V
Adv Carbohydr Chem Biochem; 2020; 77():71-117. PubMed ID: 33004112
[TBL] [Abstract][Full Text] [Related]
68. Bone marrow transplantation for feline mucopolysaccharidosis I.
Ellinwood NM; Colle MA; Weil MA; Casal ML; Vite CH; Wiemelt S; Hasson CW; O'Malley TM; He X; Prociuk U; Verot L; Melniczek JR; Lannon A; Aguirre GD; Knox VW; Evans SM; Vanier MT; Schuchman EH; Walkley SU; Haskins ME
Mol Genet Metab; 2007 Jul; 91(3):239-50. PubMed ID: 17482862
[TBL] [Abstract][Full Text] [Related]
69. Arylsulfatase K inactivation causes mucopolysaccharidosis due to deficient glucuronate desulfation of heparan and chondroitin sulfate.
Trabszo C; Ramms B; Chopra P; Lüllmann-Rauch R; Stroobants S; Sproß J; Jeschke A; Schinke T; Boons GJ; Esko JD; Lübke T; Dierks T
Biochem J; 2020 Sep; 477(17):3433-3451. PubMed ID: 32856704
[TBL] [Abstract][Full Text] [Related]
70. Effect of neonatal administration of a retroviral vector expressing alpha-L-iduronidase upon lysosomal storage in brain and other organs in mucopolysaccharidosis I mice.
Chung S; Ma X; Liu Y; Lee D; Tittiger M; Ponder KP
Mol Genet Metab; 2007 Feb; 90(2):181-92. PubMed ID: 16979922
[TBL] [Abstract][Full Text] [Related]
71. Subcutaneous implantation of microencapsulated cells overexpressing α-L-iduronidase for mucopolysaccharidosis type I treatment.
Lizzi Lagranha V; Zambiasi Martinelli B; Baldo G; Ávila Testa G; Giacomet de Carvalho T; Giugliani R; Matte U
J Mater Sci Mater Med; 2017 Mar; 28(3):43. PubMed ID: 28150116
[TBL] [Abstract][Full Text] [Related]
72. Increased longevity and metabolic correction following syngeneic BMT in a murine model of mucopolysaccharidosis type I.
Wolf DA; Lenander AW; Nan Z; Braunlin EA; Podetz-Pedersen KM; Whitley CB; Gupta P; Low WC; McIvor RS
Bone Marrow Transplant; 2012 Sep; 47(9):1235-40. PubMed ID: 22179554
[TBL] [Abstract][Full Text] [Related]
73. Shotgun proteomics reveals possible mechanisms for cognitive impairment in Mucopolysaccharidosis I mice.
Baldo G; Lorenzini DM; Santos DS; Mayer FQ; Vitry S; Bigou S; Heard JM; Matte U; Giugliani R
Mol Genet Metab; 2015 Feb; 114(2):138-45. PubMed ID: 25541102
[TBL] [Abstract][Full Text] [Related]
74. Pentosan Polysulfate: Oral Versus Subcutaneous Injection in Mucopolysaccharidosis Type I Dogs.
Simonaro CM; Tomatsu S; Sikora T; Kubaski F; Frohbergh M; Guevara JM; Wang RY; Vera M; Kang JL; Smith LJ; Schuchman EH; Haskins ME
PLoS One; 2016; 11(4):e0153136. PubMed ID: 27064989
[TBL] [Abstract][Full Text] [Related]
75. Morphologic description of male reproductive accessory glands in a mouse model of mucopolysaccharidosis type I (MPS I).
do Nascimento CC; Junior OA; D'Almeida V
J Mol Histol; 2020 Apr; 51(2):137-145. PubMed ID: 32162173
[TBL] [Abstract][Full Text] [Related]
76. Changes in hair morphology of mucopolysaccharidosis I patients treated with recombinant human alpha-L-iduronidase (laronidase, Aldurazyme).
Kloska A; Bohdanowicz J; Konopa G; Tylki-Szymńska A; Jakóbkiewicz-Banecka J; Czartoryska B; Liberek A; Wegrzyn A; Wegrzyn G
Am J Med Genet A; 2005 Dec; 139(3):199-203. PubMed ID: 16283671
[TBL] [Abstract][Full Text] [Related]
77. The efficacy of intracerebroventricular idursulfase-beta enzyme replacement therapy in mucopolysaccharidosis II murine model: heparan sulfate in cerebrospinal fluid as a clinical biomarker of neuropathology.
Sohn YB; Ko AR; Seong MR; Lee S; Kim MR; Cho SY; Kim JS; Sakaguchi M; Nakazawa T; Kosuga M; Seo JH; Okuyama T; Jin DK
J Inherit Metab Dis; 2018 Nov; 41(6):1235-1246. PubMed ID: 29978271
[TBL] [Abstract][Full Text] [Related]
78. Specific antibody titer alters the effectiveness of intrathecal enzyme replacement therapy in canine mucopolysaccharidosis I.
Dickson PI; Ellinwood NM; Brown JR; Witt RG; Le SQ; Passage MB; Vera MU; Crawford BE
Mol Genet Metab; 2012 May; 106(1):68-72. PubMed ID: 22402327
[TBL] [Abstract][Full Text] [Related]
79. Morphologic and biochemical studies of canine mucopolysaccharidosis I.
Shull RM; Helman RG; Spellacy E; Constantopoulos G; Munger RJ; Neufeld EF
Am J Pathol; 1984 Mar; 114(3):487-95. PubMed ID: 6320652
[TBL] [Abstract][Full Text] [Related]
80. Synthetic Disaccharide Standards Enable Quantitative Analysis of Stored Heparan Sulfate in MPS IIIA Murine Brain Regions.
He QQ; Trim PJ; Lau AA; King BM; Hopwood JJ; Hemsley KM; Snel MF; Ferro V
ACS Chem Neurosci; 2019 Aug; 10(8):3847-3858. PubMed ID: 31264853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
